Related Experiment Video

Updated: May 9, 2026

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer

Jonathan Welti1, Sonja Loges, Stefanie Dimmeler

  • 1Vesalius Research Center, University of Leuven, Leuven, Belgium.

The Journal of Clinical Investigation
|August 3, 2013
PubMed

Insights

Targeting cancer growth via angiogenesis has been crucial. While anti-VEGF therapy offers benefits, challenges like resistance necessitate exploring new antiangiogenic strategies.

Area of Science:

  • Oncology
  • Vascular Biology
  • Drug Development

Background:

  • Angiogenesis, the formation of new blood vessels, is a key target for blocking tumor growth.
  • Vascular Endothelial Growth Factor (VEGF) has been central to antiangiogenic therapy for cancer and ocular neovascularization.
  • Despite successes, current VEGF-targeted therapies face limitations including insufficient efficacy, intrinsic refractoriness, and acquired resistance.

Purpose of the Study:

  • To review recent advancements in understanding angiogenesis mechanisms.
  • To discuss the successes and challenges associated with current antiangiogenic therapies.
  • To highlight novel and emerging therapeutic paradigms in antiangiogenesis.

Main Methods:

  • Literature review of recent discoveries in angiogenesis.
  • Analysis of clinical outcomes and resistance mechanisms in VEGF-targeted therapy.
  • Exploration of emerging antiangiogenic strategies and targets.

Main Results:

  • New mechanisms underlying angiogenesis have been recently discovered.
  • VEGF-targeted therapy has shown benefits but is limited by resistance and efficacy issues.
  • Emerging antiangiogenic paradigms offer potential for overcoming current therapeutic challenges.

Conclusions:

  • Understanding novel angiogenesis mechanisms is key to improving antiangiogenic therapies.
  • Addressing resistance and refractoriness is critical for enhancing treatment efficacy.
  • Future research should focus on developing and validating new antiangiogenic approaches.

More Related Videos

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies09:03

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Published on: June 30, 2023

Isolation and Culture Expansion of Tumor-specific Endothelial Cells10:15

Isolation and Culture Expansion of Tumor-specific Endothelial Cells

Published on: October 14, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...